Clinical Electronic Informed Consent Market (By Type: Interactive eConsent, Static eConsent; By Application: Pharmaceutical & Biotech Companies, CROs, Hospitals & Research Centers, Others; By Region: North America, Europe, Asia Pacific, Latin America, Middle East and Africa) Industry Size, Share, Growth, Trends 2025 to 2034.
The global clinical electronic informed consent market, valued at USD 311 million in 2024, is forecast to reach USD 1,194.04 million by 2034, expanding at a 14.4% CAGR as digital solutions enhance patient engagement, compliance, and trial efficiency.
| Reports Attributes | Statistics |
| Market Size in 2024 | USD 311 Million |
| Market Size in 2025 | USD 355.78 Million |
| Market Size in 2031 | USD 797.52 Million |
| Market Size by 2034 | USD 1,194.04 Million |
| CAGR 2025 to 2034 | 14.4% |
| Base Year | 2024 |
| Forecast Period | 2025 to 2034 |
| Regions | Shares (%) |
| North America | 45% |
| Asia Pacific | 25% |
| Europe | 20% |
| LAMEA | 10% |
| Segments | Shares (%) |
| Interactive eConsent | 65% |
| Static eConsent | 35% |
| Segments | Shares (%) |
| Pharmaceutical & Biotech Companies | 40% |
| CROs | 25% |
| Hospitals & Research Centers | 20% |
| Others | 15% |
Published by Yogesh Kulkarni
